KAO JOHN E 4
4 · Alignment Healthcare, Inc. · Filed Jul 14, 2026
Research Summary
AI-generated summary of this filing
Alignment Healthcare (ALHC) CEO John Kao Sells 298,000 Shares
What Happened John E. Kao, CEO of Alignment Healthcare, sold a total of 298,000 common shares in open‑market transactions on July 10, 2026, generating total proceeds of $5,919,361. The sales were reported as two blocks: 279,644 shares at a weighted‑average price of $19.81 (proceeds $5,540,363) and 18,356 shares at a weighted‑average price of $20.65 (proceeds $378,998). Both dispositions are coded as sales (S).
Key Details
- Transaction date: 2026-07-10; Form 4 filed: 2026-07-14 (within the two‑business‑day filing window).
- Prices/ranges: larger block weighted avg $19.81 (actual trades ranged $19.55–$20.54, per footnote); smaller block weighted avg $20.65 (actual trades ranged $20.55–$20.84). Reporting person can provide a breakdown of trades by price on request.
- Total shares sold: 298,000; total proceeds: $5,919,361.
- Footnotes: sales were made under a Rule 10b5‑1 plan adopted 11/21/2025 (F1). Some securities sold are held by the JEK Trust dated 2/8/2021, of which Mr. Kao is trustee (F3).
- Shares owned after the transaction are not provided in the supplied filing details.
Context These were open‑market sales executed under a pre‑established 10b5‑1 plan, which typically schedules trades in advance and is generally viewed as routine rather than an immediate signal of insider sentiment. Multiple executions produced weighted‑average prices; the filer offers to supply per‑trade price breakdowns if requested.
Insider Transaction Report
- Sale
Common Stock
[F1][F2][F3]2026-07-10$19.81/sh−279,644$5,540,363→ 1,107,122 total(indirect: See Footnote) - Sale
Common Stock
[F1][F4][F3]2026-07-10$20.65/sh−18,356$378,998→ 1,088,766 total(indirect: See Footnote)
- 1,608,743
Common Stock
Footnotes (4)
- [F1]Date of Rule 10b5-1 plan adoption: 11/21/2025
- [F2]The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.55 to $20.54. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
- [F3]Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.
- [F4]The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.55 to $20.84. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.